Old drug, new hope: enasidenib may ease anemia in blood cancer patients
Disease control
Completed
This study tested whether enasidenib, a drug typically used for a different genetic type of leukemia, could safely improve anemia and reduce the need for blood transfusions in 17 people with lower-risk myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML) who d…
Phase: PHASE1, PHASE2 • Sponsor: Tian Yi Zhang • Aim: Disease control
Last updated May 15, 2026 11:54 UTC